BTG Pactual Asset Management US’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,879
Closed -$1.42M 299
2025
Q2
$1.42M Buy
17,879
+1,922
+12% +$153K 0.16% 107
2025
Q1
$1.43M Buy
15,957
+3,712
+30% +$347K 0.15% 124
2024
Q4
$1.22M Sell
12,245
-1,055
-8% -$109K 0.13% 138
2024
Q3
$1.51M Buy
+13,300
New +$1.58M 0.13% 137

Other funds holding MRK

BTG Pactual Asset Management US's MRK Position: Q3 2025 in Review

BTG Pactual Asset Management US sold out of Merck (MRK) in Q3 2025, closing a stake of 17,879 shares — an estimated $1.42M sold.

BTG Pactual Asset Management US first reported a position in MRK in Q3 2024 and held it in 4 quarters. The position peaked at $1.51M in Q3 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • BTG Pactual Asset Management US reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • BTG Pactual Asset Management US sold 17,879 Merck shares in Q3 2025, an estimated $1.42M.
  • BTG Pactual Asset Management US first reported a position in Merck in Q3 2024 and held it in 4 quarters.
  • BTG Pactual Asset Management US's Merck position peaked at $1.51M in Q3 2024.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on BTG Pactual Asset Management US's 13F filing for Q3 2025, filed 13 Nov 2025.